Creative Planning’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Creative Planning’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,983	Closed	-$2K	–	2132
2018 Q4	$2K	Sell	18,983 -18,372	-49%	-$12.1K	﹤0.01%	1914
2018 Q3	$64K	Buy	37,355 +5,000	+15%	+$8.95K	﹤0.01%	1848
2018 Q2	$56K	Sell	32,355 -126,050	-80%	-$218K	﹤0.01%	1839
2018 Q1	$290K	Buy	158,405 +126,300	+393%	+$267K	﹤0.01%	1362
2017 Q4	$72K	Sell	32,105 -2,100	-6%	-$5.22K	﹤0.01%	1766
2017 Q3	$99K	Sell	34,205 -117,500	-77%	-$401K	﹤0.01%	1717
2017 Q2	$675K	Buy	151,705 +23,060	+18%	+$95.1K	﹤0.01%	869
2017 Q1	$599K	Buy	128,645 +4,360	+4%	+$25.3K	﹤0.01%	899
2016 Q4	$757K	Sell	124,285 -45,470	-27%	-$238K	﹤0.01%	737
2016 Q3	$935K	Buy	169,755 +52,319	+45%	+$245K	0.01%	620
2016 Q2	$446K	Buy	117,436 +1,450	+1%	+$4.92K	﹤0.01%	836
2016 Q1	$320K	Buy	115,986 +110,486	+2,009%	+$400K	﹤0.01%	957
2015 Q4	$31K	Sell	5,500 -6,000	-52%	-$36.6K	﹤0.01%	2511
2015 Q3	$61K	Buy	+11,500	New	+$89K	﹤0.01%	1904

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Creative Planning's SGYP Position: Q1 2019 in Review

Creative Planning sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 18,983 shares — an estimated $2K sold.

Creative Planning first reported a position in SGYP in Q3 2015 and held it in 14 quarters. The position peaked at $935K in Q3 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Creative Planning reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Creative Planning sold 18,983 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
Creative Planning first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 14 quarters.
Creative Planning's Synergy Pharmaceuticals, Inc Common Stock position peaked at $935K in Q3 2016.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.